Europe Drugs for Chronic Obstructive Pulmonary Disorder Market Report 2017
- QYR999081
- 127 Pages
- February 2017
- Pharmaceuticals
Sales, means the sales volume of Drugs for Chronic Obstructive Pulmonary Disorder
Revenue, means the sales value of Drugs for Chronic Obstructive Pulmonary Disorder
This report studies sales (consumption) of Drugs for Chronic Obstructive Pulmonary Disorder in Europe market, especially in Germany, France, UK, Russia, Italy, Spain and Benelux, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering
AstraZeneca
Boehringer Ingelheim
GSK
Novartis
Teva Pharmaceuticals
Ache Laboratorios Farmaceuticos
Almirall
Aquinox Pharmaceuticals
Ario Pharma
Asmacure
Astellas Pharma
BioMarck Pharmaceuticals
Others
Market Segment by Countries, this report splits Europe into several key Countries, with sales (consumption), revenue, market share and growth rate of Drugs for Chronic Obstructive Pulmonary Disorder in these countries, from 2011 to 2021 (forecast), like
Germany
France
UK
Russia
Italy
Spain
Benelux
Split by product type, with sales, revenue, price, market share and growth rate of each type, can be divided into
Short-Acting Bronchodilators
Corticosteroids
Methylxanthines
Long-Acting Bronchodilators
Phosphodiesterase-4 Inhibitors
Split by application, this report focuses on sales, market share and growth rate of Drugs for Chronic Obstructive Pulmonary Disorder in each application, can be divided into
GOLD 1? FEV1 ? 80%
GOLD 2? 50% ? FEV1 < 80%
GOLD 3? 30% ? FEV1 < 50%
GOLD 4? FEV1 < 30%
Europe Drugs for Chronic Obstructive Pulmonary Disorder Market Report 2017
1 Drugs for Chronic Obstructive Pulmonary Disorder Overview
1.1 Product Overview and Scope of Drugs for Chronic Obstructive Pulmonary Disorder
1.2 Classification of Drugs for Chronic Obstructive Pulmonary Disorder
1.2.1 Short-Acting Bronchodilators
1.2.2 Corticosteroids
1.2.3 Methylxanthines
1.2.4 Long-Acting Bronchodilators
1.2.5 Phosphodiesterase-4 Inhibitors
1.3 Application of Drugs for Chronic Obstructive Pulmonary Disorder
1.3.1 GOLD 1? FEV1 ? 80%
1.3.2 GOLD 2? 50% ? FEV1 < 80%
1.3.3 GOLD 3? 30% ? FEV1 < 50%
1.3.4 GOLD 4? FEV1 < 30%
1.4 Drugs for Chronic Obstructive Pulmonary Disorder Market by Countries
1.4.1 Germany Status and Prospect (2012-2022)
1.4.2 France Status and Prospect (2012-2022)
1.4.3 UK Status and Prospect (2012-2022)
1.4.4 Russia Status and Prospect (2012-2022)
1.4.5 Italy Status and Prospect (2012-2022)
1.4.6 Spain Status and Prospect (2012-2022)
1.4.7 Benelux Status and Prospect (2012-2022)
1.5 Europe Market Size (Value and Volume) of Drugs for Chronic Obstructive Pulmonary Disorder (2012-2022)
1.5.1 Europe Drugs for Chronic Obstructive Pulmonary Disorder Sales and Growth Rate (2012-2022)
1.5.2 Europe Drugs for Chronic Obstructive Pulmonary Disorder Revenue and Growth Rate (2012-2022)
2 Europe Drugs for Chronic Obstructive Pulmonary Disorder by Manufacturers, Type and Application
2.1 Europe Drugs for Chronic Obstructive Pulmonary Disorder Market Competition by Manufacturers
2.1.1 Europe Drugs for Chronic Obstructive Pulmonary Disorder Sales and Market Share of Key Manufacturers (2015 and 2016)
2.1.2 Europe Drugs for Chronic Obstructive Pulmonary Disorder Revenue and Share by Manufacturers (2015 and 2016)
2.2 Europe Drugs for Chronic Obstructive Pulmonary Disorder (Volume and Value) by Type
2.2.1 Europe Drugs for Chronic Obstructive Pulmonary Disorder Sales and Market Share by Type (2012-2017)
2.2.2 Europe Drugs for Chronic Obstructive Pulmonary Disorder Revenue and Market Share by Type (2012-2017)
2.3 Europe Drugs for Chronic Obstructive Pulmonary Disorder (Volume and Value) by Countries
2.3.1 Europe Drugs for Chronic Obstructive Pulmonary Disorder Sales and Market Share by Countries (2012-2017)
2.3.2 Europe Drugs for Chronic Obstructive Pulmonary Disorder Revenue and Market Share by Countries (2012-2017)
2.4 Europe Drugs for Chronic Obstructive Pulmonary Disorder (Volume) by Application
3 Germany Drugs for Chronic Obstructive Pulmonary Disorder (Volume, Value and Sales Price)
3.1 Germany Drugs for Chronic Obstructive Pulmonary Disorder Sales and Value (2012-2017)
3.1.1 Germany Drugs for Chronic Obstructive Pulmonary Disorder Sales and Growth Rate (2012-2017)
3.1.2 Germany Drugs for Chronic Obstructive Pulmonary Disorder Revenue and Growth Rate (2012-2017)
3.1.3 Germany Drugs for Chronic Obstructive Pulmonary Disorder Sales Price Trend (2012-2017)
3.2 Germany Drugs for Chronic Obstructive Pulmonary Disorder Sales and Market Share by Manufacturers
3.3 Germany Drugs for Chronic Obstructive Pulmonary Disorder Sales and Market Share by Type
3.4 Germany Drugs for Chronic Obstructive Pulmonary Disorder Sales and Market Share by Application
4 France Drugs for Chronic Obstructive Pulmonary Disorder (Volume, Value and Sales Price)
4.1 France Drugs for Chronic Obstructive Pulmonary Disorder Sales and Value (2012-2017)
4.1.1 France Drugs for Chronic Obstructive Pulmonary Disorder Sales and Growth Rate (2012-2017)
4.1.2 France Drugs for Chronic Obstructive Pulmonary Disorder Revenue and Growth Rate (2012-2017)
4.1.4 France Drugs for Chronic Obstructive Pulmonary Disorder Sales Price Trend (2012-2017)
4.2 France Drugs for Chronic Obstructive Pulmonary Disorder Sales and Market Share by Manufacturers
4.3 France Drugs for Chronic Obstructive Pulmonary Disorder Sales and Market Share by Type
4.4 France Drugs for Chronic Obstructive Pulmonary Disorder Sales and Market Share by Application
5 UK Drugs for Chronic Obstructive Pulmonary Disorder (Volume, Value and Sales Price)
5.1 UK Drugs for Chronic Obstructive Pulmonary Disorder Sales and Value (2012-2017)
5.1.1 UK Drugs for Chronic Obstructive Pulmonary Disorder Sales and Growth Rate (2012-2017)
5.1.2 UK Drugs for Chronic Obstructive Pulmonary Disorder Revenue and Growth Rate (2012-2017)
5.1.5 UK Drugs for Chronic Obstructive Pulmonary Disorder Sales Price Trend (2012-2017)
5.2 UK Drugs for Chronic Obstructive Pulmonary Disorder Sales and Market Share by Manufacturers
5.3 UK Drugs for Chronic Obstructive Pulmonary Disorder Sales and Market Share by Type
5.4 UK Drugs for Chronic Obstructive Pulmonary Disorder Sales and Market Share by Application
6 Russia Drugs for Chronic Obstructive Pulmonary Disorder (Volume, Value and Sales Price)
6.1 Russia Drugs for Chronic Obstructive Pulmonary Disorder Sales and Value (2012-2017)
6.1.1 Russia Drugs for Chronic Obstructive Pulmonary Disorder Sales and Growth Rate (2012-2017)
6.1.2 Russia Drugs for Chronic Obstructive Pulmonary Disorder Revenue and Growth Rate (2012-2017)
6.1.6 Russia Drugs for Chronic Obstructive Pulmonary Disorder Sales Price Trend (2012-2017)
6.2 Russia Drugs for Chronic Obstructive Pulmonary Disorder Sales and Market Share by Manufacturers
6.3 Russia Drugs for Chronic Obstructive Pulmonary Disorder Sales and Market Share by Type
6.4 Russia Drugs for Chronic Obstructive Pulmonary Disorder Sales and Market Share by Application
7 Italy Drugs for Chronic Obstructive Pulmonary Disorder (Volume, Value and Sales Price)
7.1 Italy Drugs for Chronic Obstructive Pulmonary Disorder Sales and Value (2012-2017)
7.1.1 Italy Drugs for Chronic Obstructive Pulmonary Disorder Sales and Growth Rate (2012-2017)
7.1.2 Italy Drugs for Chronic Obstructive Pulmonary Disorder Revenue and Growth Rate (2012-2017)
7.1.7 Italy Drugs for Chronic Obstructive Pulmonary Disorder Sales Price Trend (2012-2017)
7.2 Italy Drugs for Chronic Obstructive Pulmonary Disorder Sales and Market Share by Manufacturers
7.3 Italy Drugs for Chronic Obstructive Pulmonary Disorder Sales and Market Share by Type
7.4 Italy Drugs for Chronic Obstructive Pulmonary Disorder Sales and Market Share by Application
8 Spain Drugs for Chronic Obstructive Pulmonary Disorder (Volume, Value and Sales Price)
8.1 Spain Drugs for Chronic Obstructive Pulmonary Disorder Sales and Value (2012-2017)
8.1.1 Spain Drugs for Chronic Obstructive Pulmonary Disorder Sales and Growth Rate (2012-2017)
8.1.2 Spain Drugs for Chronic Obstructive Pulmonary Disorder Revenue and Growth Rate (2012-2017)
8.1.8 Spain Drugs for Chronic Obstructive Pulmonary Disorder Sales Price Trend (2012-2017)
8.2 Spain Drugs for Chronic Obstructive Pulmonary Disorder Sales and Market Share by Manufacturers
8.3 Spain Drugs for Chronic Obstructive Pulmonary Disorder Sales and Market Share by Type
8.4 Spain Drugs for Chronic Obstructive Pulmonary Disorder Sales and Market Share by Application
9 Benelux Drugs for Chronic Obstructive Pulmonary Disorder (Volume, Value and Sales Price)
9.1 Benelux Drugs for Chronic Obstructive Pulmonary Disorder Sales and Value (2012-2017)
9.1.1 Benelux Drugs for Chronic Obstructive Pulmonary Disorder Sales and Growth Rate (2012-2017)
9.1.2 Benelux Drugs for Chronic Obstructive Pulmonary Disorder Revenue and Growth Rate (2012-2017)
9.1.9 Benelux Drugs for Chronic Obstructive Pulmonary Disorder Sales Price Trend (2012-2017)
9.2 Benelux Drugs for Chronic Obstructive Pulmonary Disorder Sales and Market Share by Manufacturers
9.3 Benelux Drugs for Chronic Obstructive Pulmonary Disorder Sales and Market Share by Type
9.4 Benelux Drugs for Chronic Obstructive Pulmonary Disorder Sales and Market Share by Application
10 Europe Drugs for Chronic Obstructive Pulmonary Disorder Manufacturers Analysis
10.1 AstraZeneca
10.1.1 Company Basic Information, Manufacturing Base and Competitors
10.1.2 Drugs for Chronic Obstructive Pulmonary Disorder Product Type, Application and Specification
10.1.2.1 Short-Acting Bronchodilators
10.1.2.2 Corticosteroids
10.1.3 AstraZeneca Drugs for Chronic Obstructive Pulmonary Disorder Sales, Revenue, Price and Gross Margin (2012-2017)
10.1.4 Main Business/Business Overview
10.2 Boehringer Ingelheim
10.2.1 Company Basic Information, Manufacturing Base and Competitors
10.2.2 Drugs for Chronic Obstructive Pulmonary Disorder Product Type, Application and Specification
10.2.2.1 Short-Acting Bronchodilators
10.2.2.2 Corticosteroids
10.2.3 Boehringer Ingelheim Drugs for Chronic Obstructive Pulmonary Disorder Sales, Revenue, Price and Gross Margin (2012-2017)
10.2.4 Main Business/Business Overview
10.3 GSK
10.3.1 Company Basic Information, Manufacturing Base and Competitors
10.3.2 Drugs for Chronic Obstructive Pulmonary Disorder Product Type, Application and Specification
10.3.2.1 Short-Acting Bronchodilators
10.3.2.2 Corticosteroids
10.3.3 GSK Drugs for Chronic Obstructive Pulmonary Disorder Sales, Revenue, Price and Gross Margin (2012-2017)
10.3.4 Main Business/Business Overview
10.4 Novartis
10.4.1 Company Basic Information, Manufacturing Base and Competitors
10.4.2 Drugs for Chronic Obstructive Pulmonary Disorder Product Type, Application and Specification
10.4.2.1 Short-Acting Bronchodilators
10.4.2.2 Corticosteroids
10.4.3 Novartis Drugs for Chronic Obstructive Pulmonary Disorder Sales, Revenue, Price and Gross Margin (2012-2017)
10.4.4 Main Business/Business Overview
10.5 Teva Pharmaceuticals
10.5.1 Company Basic Information, Manufacturing Base and Competitors
10.5.2 Drugs for Chronic Obstructive Pulmonary Disorder Product Type, Application and Specification
10.5.2.1 Short-Acting Bronchodilators
10.5.2.2 Corticosteroids
10.5.3 Teva Pharmaceuticals Drugs for Chronic Obstructive Pulmonary Disorder Sales, Revenue, Price and Gross Margin (2012-2017)
10.5.4 Main Business/Business Overview
10.6 Ache Laboratorios Farmaceuticos
10.6.1 Company Basic Information, Manufacturing Base and Competitors
10.6.2 Drugs for Chronic Obstructive Pulmonary Disorder Product Type, Application and Specification
10.6.2.1 Short-Acting Bronchodilators
10.6.2.2 Corticosteroids
10.6.3 Ache Laboratorios Farmaceuticos Drugs for Chronic Obstructive Pulmonary Disorder Sales, Revenue, Price and Gross Margin (2012-2017)
10.6.4 Main Business/Business Overview
10.7 Almirall
10.7.1 Company Basic Information, Manufacturing Base and Competitors
10.7.2 Drugs for Chronic Obstructive Pulmonary Disorder Product Type, Application and Specification
10.7.2.1 Short-Acting Bronchodilators
10.7.2.2 Corticosteroids
10.7.3 Almirall Drugs for Chronic Obstructive Pulmonary Disorder Sales, Revenue, Price and Gross Margin (2012-2017)
10.7.4 Main Business/Business Overview
10.8 Aquinox Pharmaceuticals
10.8.1 Company Basic Information, Manufacturing Base and Competitors
10.8.2 Drugs for Chronic Obstructive Pulmonary Disorder Product Type, Application and Specification
10.8.2.1 Short-Acting Bronchodilators
10.8.2.2 Corticosteroids
10.8.3 Aquinox Pharmaceuticals Drugs for Chronic Obstructive Pulmonary Disorder Sales, Revenue, Price and Gross Margin (2012-2017)
10.8.4 Main Business/Business Overview
10.9 Ario Pharma
10.9.1 Company Basic Information, Manufacturing Base and Competitors
10.9.2 Drugs for Chronic Obstructive Pulmonary Disorder Product Type, Application and Specification
10.9.2.1 Short-Acting Bronchodilators
10.9.2.2 Corticosteroids
10.9.3 Ario Pharma Drugs for Chronic Obstructive Pulmonary Disorder Sales, Revenue, Price and Gross Margin (2012-2017)
10.9.4 Main Business/Business Overview
10.10 Asmacure
10.10.1 Company Basic Information, Manufacturing Base and Competitors
10.10.2 Drugs for Chronic Obstructive Pulmonary Disorder Product Type, Application and Specification
10.10.2.1 Short-Acting Bronchodilators
10.10.2.2 Corticosteroids
10.10.3 Asmacure Drugs for Chronic Obstructive Pulmonary Disorder Sales, Revenue, Price and Gross Margin (2012-2017)
10.10.4 Main Business/Business Overview
10.11 Astellas Pharma
10.12 BioMarck Pharmaceuticals
10.13 Others
11 Drugs for Chronic Obstructive Pulmonary Disorder Manufacturing Cost Analysis
11.1 Drugs for Chronic Obstructive Pulmonary Disorder Key Raw Materials Analysis
11.1.1 Key Raw Materials
11.1.2 Price Trend of Key Raw Materials
11.1.3 Key Suppliers of Raw Materials
11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Drugs for Chronic Obstructive Pulmonary Disorder
12 Industrial Chain, Sourcing Strategy and Downstream Buyers
12.1 Drugs for Chronic Obstructive Pulmonary Disorder Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Drugs for Chronic Obstructive Pulmonary Disorder Major Manufacturers in 2015
12.4 Downstream Buyers
13 Marketing Strategy Analysis, Distributors/Traders
13.1 Marketing Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
13.2.1 Pricing Strategy
13.2.2 Brand Strategy
13.2.3 Target Client
13.3 Distributors/Traders List
14 Europe Drugs for Chronic Obstructive Pulmonary Disorder Market Forecast (2017-2022)
14.1 Germany Drugs for Chronic Obstructive Pulmonary Disorder Sales Forecast (2017-2022)
14.2 France Drugs for Chronic Obstructive Pulmonary Disorder Sales Forecast (2017-2022)
14.3 UK Drugs for Chronic Obstructive Pulmonary Disorder Sales Forecast (2017-2022)
14.4 Russia Drugs for Chronic Obstructive Pulmonary Disorder Sales Forecast (2017-2022)
14.5 Italy Drugs for Chronic Obstructive Pulmonary Disorder Sales Forecast (2017-2022)
14.6 Spain Drugs for Chronic Obstructive Pulmonary Disorder Sales Forecast (2017-2022)
14.7 Benelux Drugs for Chronic Obstructive Pulmonary Disorder Sales Forecast (2017-2022)
14.8 Europe Drugs for Chronic Obstructive Pulmonary Disorder Sales Forecast by Type (2017-2022)
14.9 Europe Drugs for Chronic Obstructive Pulmonary Disorder Sales Forecast by Application (2017-2022)
15 Research Findings and Conclusion
16 Appendix
Methodology
Analyst Introduction
Data Source
Figure Picture of Drugs for Chronic Obstructive Pulmonary Disorder
Table Classification of Drugs for Chronic Obstructive Pulmonary Disorder
Figure Europe Sales Market Share of Drugs for Chronic Obstructive Pulmonary Disorder by Type in 2015
Figure Short-Acting Bronchodilators Picture
Figure Corticosteroids Picture
Figure Methylxanthines Picture
Figure Long-Acting Bronchodilators Picture
Figure Phosphodiesterase-4 Inhibitors Picture
Table Application of Drugs for Chronic Obstructive Pulmonary Disorder
Figure Europe Sales Market Share of Drugs for Chronic Obstructive Pulmonary Disorder by Application in 2015
Figure GOLD 1? FEV1 ? 80% Examples
Figure GOLD 2? 50% ? FEV1 < 80% Examples
Figure GOLD 3? 30% ? FEV1 < 50% Examples
Figure GOLD 4? FEV1 < 30% Examples
Figure Germany Drugs for Chronic Obstructive Pulmonary Disorder Revenue and Growth Rate (2012-2022)
Figure France Drugs for Chronic Obstructive Pulmonary Disorder Revenue and Growth Rate (2012-2022)
Figure UK Drugs for Chronic Obstructive Pulmonary Disorder Revenue and Growth Rate (2012-2022)
Figure Russia Drugs for Chronic Obstructive Pulmonary Disorder Revenue and Growth Rate (2012-2022)
Figure Italy Drugs for Chronic Obstructive Pulmonary Disorder Revenue and Growth Rate (2012-2022)
Figure Spain Drugs for Chronic Obstructive Pulmonary Disorder Revenue and Growth Rate (2012-2022)
Figure Benelux Drugs for Chronic Obstructive Pulmonary Disorder Revenue and Growth Rate (2012-2022)
Figure Europe Drugs for Chronic Obstructive Pulmonary Disorder Sales and Growth Rate (2012-2022)
Figure Europe Drugs for Chronic Obstructive Pulmonary Disorder Revenue and Growth Rate (2012-2022)
Table Europe Drugs for Chronic Obstructive Pulmonary Disorder Sales of Key Manufacturers (2015 and 2016)
Table Europe Drugs for Chronic Obstructive Pulmonary Disorder Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Drugs for Chronic Obstructive Pulmonary Disorder Sales Share by Manufacturers
Figure 2016 Drugs for Chronic Obstructive Pulmonary Disorder Sales Share by Manufacturers
Table Europe Drugs for Chronic Obstructive Pulmonary Disorder Revenue by Manufacturers (2015 and 2016)
Table Europe Drugs for Chronic Obstructive Pulmonary Disorder Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Europe Drugs for Chronic Obstructive Pulmonary Disorder Revenue Share by Manufacturers
Table 2016 Europe Drugs for Chronic Obstructive Pulmonary Disorder Revenue Share by Manufacturers
Table Europe Drugs for Chronic Obstructive Pulmonary Disorder Sales and Market Share by Type (2012-2017)
Table Europe Drugs for Chronic Obstructive Pulmonary Disorder Sales Share by Type (2012-2017)
Figure Sales Market Share of Drugs for Chronic Obstructive Pulmonary Disorder by Type (2012-2017)
Figure Europe Drugs for Chronic Obstructive Pulmonary Disorder Sales Growth Rate by Type (2012-2017)
Table Europe Drugs for Chronic Obstructive Pulmonary Disorder Revenue and Market Share by Type (2012-2017)
Table Europe Drugs for Chronic Obstructive Pulmonary Disorder Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Drugs for Chronic Obstructive Pulmonary Disorder by Type (2012-2017)
Figure Europe Drugs for Chronic Obstructive Pulmonary Disorder Revenue Growth Rate by Type (2012-2017)
Table Europe Drugs for Chronic Obstructive Pulmonary Disorder Sales and Market Share by Countries (2012-2017)
Table Europe Drugs for Chronic Obstructive Pulmonary Disorder Sales Share by Countries (2012-2017)
Figure Sales Market Share of Drugs for Chronic Obstructive Pulmonary Disorder by Countries (2012-2017)
Table Europe Drugs for Chronic Obstructive Pulmonary Disorder Revenue and Market Share by Countries (2012-2017)
Table Europe Drugs for Chronic Obstructive Pulmonary Disorder Revenue Share by Countries (2012-2017)
Figure Revenue Market Share of Drugs for Chronic Obstructive Pulmonary Disorder by Countries (2012-2017)
Table Europe Drugs for Chronic Obstructive Pulmonary Disorder Sales and Market Share by Application (2012-2017)
Table Europe Drugs for Chronic Obstructive Pulmonary Disorder Sales Share by Application (2012-2017)
Figure Sales Market Share of Drugs for Chronic Obstructive Pulmonary Disorder by Application (2012-2017)
Figure Germany Drugs for Chronic Obstructive Pulmonary Disorder Sales and Growth Rate (2012-2017)
Figure Germany Drugs for Chronic Obstructive Pulmonary Disorder Revenue and Growth Rate (2012-2017)
Figure Germany Drugs for Chronic Obstructive Pulmonary Disorder Sales Price Trend (2012-2017)
Table Germany Drugs for Chronic Obstructive Pulmonary Disorder Sales by Manufacturers (2015 and 2016)
Table Germany Drugs for Chronic Obstructive Pulmonary Disorder Market Share by Manufacturers (2015 and 2016)
Table Germany Drugs for Chronic Obstructive Pulmonary Disorder Sales by Type (2015 and 2016)
Table Germany Drugs for Chronic Obstructive Pulmonary Disorder Market Share by Type (2015 and 2016)
Table Germany Drugs for Chronic Obstructive Pulmonary Disorder Sales by Application (2015 and 2016)
Table Germany Drugs for Chronic Obstructive Pulmonary Disorder Market Share by Application (2015 and 2016)
Figure France Drugs for Chronic Obstructive Pulmonary Disorder Sales and Growth Rate (2012-2017)
Figure France Drugs for Chronic Obstructive Pulmonary Disorder Revenue and Growth Rate (2012-2017)
Figure France Drugs for Chronic Obstructive Pulmonary Disorder Sales Price Trend (2012-2017)
Table France Drugs for Chronic Obstructive Pulmonary Disorder Sales by Manufacturers (2015 and 2016)
Table France Drugs for Chronic Obstructive Pulmonary Disorder Market Share by Manufacturers (2015 and 2016)
Table France Drugs for Chronic Obstructive Pulmonary Disorder Sales by Type (2015 and 2016)
Table France Drugs for Chronic Obstructive Pulmonary Disorder Market Share by Type (2015 and 2016)
Table France Drugs for Chronic Obstructive Pulmonary Disorder Sales by Application (2015 and 2016)
Table France Drugs for Chronic Obstructive Pulmonary Disorder Market Share by Application (2015 and 2016)
Figure UK Drugs for Chronic Obstructive Pulmonary Disorder Sales and Growth Rate (2012-2017)
Figure UK Drugs for Chronic Obstructive Pulmonary Disorder Revenue and Growth Rate (2012-2017)
Figure UK Drugs for Chronic Obstructive Pulmonary Disorder Sales Price Trend (2012-2017)
Table UK Drugs for Chronic Obstructive Pulmonary Disorder Sales by Manufacturers (2015 and 2016)
Table UK Drugs for Chronic Obstructive Pulmonary Disorder Market Share by Manufacturers (2015 and 2016)
Table UK Drugs for Chronic Obstructive Pulmonary Disorder Sales by Type (2015 and 2016)
Table UK Drugs for Chronic Obstructive Pulmonary Disorder Market Share by Type (2015 and 2016)
Table UK Drugs for Chronic Obstructive Pulmonary Disorder Sales by Application (2015 and 2016)
Table UK Drugs for Chronic Obstructive Pulmonary Disorder Market Share by Application (2015 and 2016)
Figure Russia Drugs for Chronic Obstructive Pulmonary Disorder Sales and Growth Rate (2012-2017)
Figure Russia Drugs for Chronic Obstructive Pulmonary Disorder Revenue and Growth Rate (2012-2017)
Figure Russia Drugs for Chronic Obstructive Pulmonary Disorder Sales Price Trend (2012-2017)
Table Russia Drugs for Chronic Obstructive Pulmonary Disorder Sales by Manufacturers (2015 and 2016)
Table Russia Drugs for Chronic Obstructive Pulmonary Disorder Market Share by Manufacturers (2015 and 2016)
Table Russia Drugs for Chronic Obstructive Pulmonary Disorder Sales by Type (2015 and 2016)
Table Russia Drugs for Chronic Obstructive Pulmonary Disorder Market Share by Type (2015 and 2016)
Table Russia Drugs for Chronic Obstructive Pulmonary Disorder Sales by Application (2015 and 2016)
Table Russia Drugs for Chronic Obstructive Pulmonary Disorder Market Share by Application (2015 and 2016)
Figure Italy Drugs for Chronic Obstructive Pulmonary Disorder Sales and Growth Rate (2012-2017)
Figure Italy Drugs for Chronic Obstructive Pulmonary Disorder Revenue and Growth Rate (2012-2017)
Figure Italy Drugs for Chronic Obstructive Pulmonary Disorder Sales Price Trend (2012-2017)
Table Italy Drugs for Chronic Obstructive Pulmonary Disorder Sales by Manufacturers (2015 and 2016)
Table Italy Drugs for Chronic Obstructive Pulmonary Disorder Market Share by Manufacturers (2015 and 2016)
Table Italy Drugs for Chronic Obstructive Pulmonary Disorder Sales by Type (2015 and 2016)
Table Italy Drugs for Chronic Obstructive Pulmonary Disorder Market Share by Type (2015 and 2016)
Table Italy Drugs for Chronic Obstructive Pulmonary Disorder Sales by Application (2015 and 2016)
Table Italy Drugs for Chronic Obstructive Pulmonary Disorder Market Share by Application (2015 and 2016)
Figure Spain Drugs for Chronic Obstructive Pulmonary Disorder Sales and Growth Rate (2012-2017)
Figure Spain Drugs for Chronic Obstructive Pulmonary Disorder Revenue and Growth Rate (2012-2017)
Figure Spain Drugs for Chronic Obstructive Pulmonary Disorder Sales Price Trend (2012-2017)
Table Spain Drugs for Chronic Obstructive Pulmonary Disorder Sales by Manufacturers (2015 and 2016)
Table Spain Drugs for Chronic Obstructive Pulmonary Disorder Market Share by Manufacturers (2015 and 2016)
Table Spain Drugs for Chronic Obstructive Pulmonary Disorder Sales by Type (2015 and 2016)
Table Spain Drugs for Chronic Obstructive Pulmonary Disorder Market Share by Type (2015 and 2016)
Table Spain Drugs for Chronic Obstructive Pulmonary Disorder Sales by Application (2015 and 2016)
Table Spain Drugs for Chronic Obstructive Pulmonary Disorder Market Share by Application (2015 and 2016)
Figure Benelux Drugs for Chronic Obstructive Pulmonary Disorder Sales and Growth Rate (2012-2017)
Figure Benelux Drugs for Chronic Obstructive Pulmonary Disorder Revenue and Growth Rate (2012-2017)
Figure Benelux Drugs for Chronic Obstructive Pulmonary Disorder Sales Price Trend (2012-2017)
Table Benelux Drugs for Chronic Obstructive Pulmonary Disorder Sales by Manufacturers (2015 and 2016)
Table Benelux Drugs for Chronic Obstructive Pulmonary Disorder Market Share by Manufacturers (2015 and 2016)
Table Benelux Drugs for Chronic Obstructive Pulmonary Disorder Sales by Type (2015 and 2016)
Table Benelux Drugs for Chronic Obstructive Pulmonary Disorder Market Share by Type (2015 and 2016)
Table Benelux Drugs for Chronic Obstructive Pulmonary Disorder Sales by Application (2015 and 2016)
Table Benelux Drugs for Chronic Obstructive Pulmonary Disorder Market Share by Application (2015 and 2016)
Table Drugs for Chronic Obstructive Pulmonary Disorder Basic Information List
Table AstraZeneca Drugs for Chronic Obstructive Pulmonary Disorder Sales, Revenue, Price and Gross Margin (2012-2017)
Figure AstraZeneca Drugs for Chronic Obstructive Pulmonary Disorder Sales Market Share (2012-2017)
Table Boehringer Ingelheim Basic Information List
Table Boehringer Ingelheim Drugs for Chronic Obstructive Pulmonary Disorder Sales, Revenue, Price and Gross Margin (2012-2017)
Table Boehringer Ingelheim Drugs for Chronic Obstructive Pulmonary Disorder Sales Market Share (2012-2017)
Table GSK Basic Information List
Table GSK Drugs for Chronic Obstructive Pulmonary Disorder Sales, Revenue, Price and Gross Margin (2012-2017)
Table GSK Drugs for Chronic Obstructive Pulmonary Disorder Sales Market Share (2012-2017)
Table Novartis Basic Information List
Table Novartis Drugs for Chronic Obstructive Pulmonary Disorder Sales, Revenue, Price and Gross Margin (2012-2017)
Table Novartis Drugs for Chronic Obstructive Pulmonary Disorder Sales Market Share (2012-2017)
Table Teva Pharmaceuticals Basic Information List
Table Teva Pharmaceuticals Drugs for Chronic Obstructive Pulmonary Disorder Sales, Revenue, Price and Gross Margin (2012-2017)
Table Teva Pharmaceuticals Drugs for Chronic Obstructive Pulmonary Disorder Sales Market Share (2012-2017)
Table Ache Laboratorios Farmaceuticos Basic Information List
Table Ache Laboratorios Farmaceuticos Drugs for Chronic Obstructive Pulmonary Disorder Sales, Revenue, Price and Gross Margin (2012-2017)
Table Ache Laboratorios Farmaceuticos Drugs for Chronic Obstructive Pulmonary Disorder Sales Market Share (2012-2017)
Table Almirall Basic Information List
Table Almirall Drugs for Chronic Obstructive Pulmonary Disorder Sales, Revenue, Price and Gross Margin (2012-2017)
Table Almirall Drugs for Chronic Obstructive Pulmonary Disorder Sales Market Share (2012-2017)
Table Aquinox Pharmaceuticals Basic Information List
Table Aquinox Pharmaceuticals Drugs for Chronic Obstructive Pulmonary Disorder Sales, Revenue, Price and Gross Margin (2012-2017)
Table Aquinox Pharmaceuticals Drugs for Chronic Obstructive Pulmonary Disorder Sales Market Share (2012-2017)
Table Ario Pharma Basic Information List
Table Ario Pharma Drugs for Chronic Obstructive Pulmonary Disorder Sales, Revenue, Price and Gross Margin (2012-2017)
Table Ario Pharma Drugs for Chronic Obstructive Pulmonary Disorder Sales Market Share (2012-2017)
Table Asmacure Basic Information List
Table Asmacure Drugs for Chronic Obstructive Pulmonary Disorder Sales, Revenue, Price and Gross Margin (2012-2017)
Table Asmacure Drugs for Chronic Obstructive Pulmonary Disorder Sales Market Share (2012-2017)
Table Astellas Pharma Basic Information List
Table BioMarck Pharmaceuticals Basic Information List
Table Others Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Drugs for Chronic Obstructive Pulmonary Disorder
Figure Manufacturing Process Analysis of Drugs for Chronic Obstructive Pulmonary Disorder
Figure Drugs for Chronic Obstructive Pulmonary Disorder Industrial Chain Analysis
Table Raw Materials Sources of Drugs for Chronic Obstructive Pulmonary Disorder Major Manufacturers in 2015
Table Major Buyers of Drugs for Chronic Obstructive Pulmonary Disorder
Table Distributors/Traders List
Figure Germany Drugs for Chronic Obstructive Pulmonary Disorder Sales and Growth Rate Forecast (2017-2022)
Figure Germany Drugs for Chronic Obstructive Pulmonary Disorder Revenue and Growth Rate Forecast (2017-2022)
Figure France Drugs for Chronic Obstructive Pulmonary Disorder Sales and Growth Rate Forecast (2017-2022)
Figure France Drugs for Chronic Obstructive Pulmonary Disorder Revenue and Growth Rate Forecast (2017-2022)
Figure UK Drugs for Chronic Obstructive Pulmonary Disorder Sales and Growth Rate Forecast (2017-2022)
Figure UK Drugs for Chronic Obstructive Pulmonary Disorder Revenue and Growth Rate Forecast (2017-2022)
Figure Russia Drugs for Chronic Obstructive Pulmonary Disorder Sales and Growth Rate Forecast (2017-2022)
Figure Russia Drugs for Chronic Obstructive Pulmonary Disorder Revenue and Growth Rate Forecast (2017-2022)
Figure Italy Drugs for Chronic Obstructive Pulmonary Disorder Sales and Growth Rate Forecast (2017-2022)
Figure Italy Drugs for Chronic Obstructive Pulmonary Disorder Revenue and Growth Rate Forecast (2017-2022)
Figure Spain Drugs for Chronic Obstructive Pulmonary Disorder Sales and Growth Rate Forecast (2017-2022)
Figure Spain Drugs for Chronic Obstructive Pulmonary Disorder Revenue and Growth Rate Forecast (2017-2022)
Figure Benelux Drugs for Chronic Obstructive Pulmonary Disorder Sales and Growth Rate Forecast (2017-2022)
Figure Benelux Drugs for Chronic Obstructive Pulmonary Disorder Revenue and Growth Rate Forecast (2017-2022)
Table Europe Drugs for Chronic Obstructive Pulmonary Disorder Sales Forecast by Type (2017-2022)
Table Europe Drugs for Chronic Obstructive Pulmonary Disorder Sales Forecast by Application (2017-2022)
Similar Reports
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
- Publish Date: November 14, 2017
- $5370
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
- Publish Date: July 20, 2017
- $5370
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...
- Publish Date: April 24, 2017
- $5370
